Utah Medical Products (UTMD) Q1 2025 Earnings
UTMD·Reported April 29, 2025·Before market open
Utah Medical Products reported Q1 2025 revenue of $9.7M (-14.4% YoY). Diluted EPS came in at $0.92 (-15.6% YoY).
Revenue
$9.7M
Diluted EPS
$0.92
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Utah Medical Products's Q1 2025 earnings report.
Utah Medical Products (UTMD) reported Q1 2025 earnings on April 29, 2025 before market open.
Utah Medical Products reported revenue of $9.7M and diluted EPS of $0.92 for Q1 2025.
Compared to the same quarter a year prior, revenue declined 14.4% from $11.3M a year earlier and diluted EPS declined 15.6% from $1.09.
You can read the 10-Q periodic report (0001096906-25-000816) directly on SEC EDGAR. The filing index links above go to sec.gov.